ClinicalTrials.gov
public full text
Public Domain
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood#1464984
- Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.#1087207
- Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood#867893
- Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood#1444983
- T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients#883633
Record · ID 1496906
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive